CONDOR CAPITAL MANAGEMENT - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
CONDOR CAPITAL MANAGEMENT ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2021$748,000
-4.0%
19,5650.0%0.08%
-7.0%
Q2 2021$779,000
+11.6%
19,5650.0%0.09%
+3.6%
Q1 2021$698,000
-3.1%
19,5650.0%0.08%
-8.8%
Q4 2020$720,000
-2.2%
19,5650.0%0.09%
-15.0%
Q3 2020$736,000
-7.8%
19,5650.0%0.11%
-13.0%
Q2 2020$798,000
+7.7%
19,5650.0%0.12%
-10.2%
Q1 2020$741,000
-19.4%
19,5650.0%0.14%
+1.5%
Q4 2019$919,000
+8.1%
19,565
-1.8%
0.14%
+2.3%
Q3 2019$850,000
+4.8%
19,921
-1.8%
0.13%
+4.8%
Q2 2019$811,000
-4.3%
20,2770.0%0.13%
-8.7%
Q1 2019$847,000
+9.3%
20,2770.0%0.14%
-2.1%
Q4 2018$775,000
-4.9%
20,2770.0%0.14%
-5.4%
Q3 2018$815,000
-0.2%
20,277
+0.0%
0.15%
-5.1%
Q2 2018$817,000
+1.4%
20,275
-1.7%
0.16%
-10.3%
Q1 2018$806,000
+10.1%
20,6310.0%0.18%
+17.4%
Q4 2017$732,000
-12.6%
20,6310.0%0.15%
-11.3%
Q3 2017$838,000
-5.8%
20,6310.0%0.17%
-10.6%
Q2 2017$890,000
+2.3%
20,6310.0%0.19%
+0.5%
Q1 2017$870,000
+9.6%
20,6310.0%0.19%
+5.6%
Q4 2016$794,000
-10.8%
20,6310.0%0.18%
-14.9%
Q3 2016$890,000
-0.9%
20,631
-0.4%
0.21%
-3.3%
Q2 2016$898,000
+6.9%
20,7160.0%0.22%
+5.9%
Q1 2016$840,000
+0.5%
20,7160.0%0.20%
-0.5%
Q4 2015$836,000
+4.9%
20,7160.0%0.20%
-1.9%
Q3 2015$797,000
-7.6%
20,7160.0%0.21%
+0.5%
Q2 2015$863,000
-9.8%
20,716
-0.1%
0.21%
-8.8%
Q1 2015$957,00020,7410.23%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2018
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders